Search results
May 18, 2021 · The USPSTF concludes with moderate certainty that screening for colorectal cancer in adults aged 76 to 85 years who have been previously screened has small net benefit. Adults who have never been screened for colorectal cancer are more likely to benefit.
The Task Force recommends screening for colon and rectal cancer between ages 50 and 75 years using colonoscopy or any other available test (A recommendation). For adults aged 76 to 85 years, the Task Force recommends that the decision to screen should take into account the patient’s health and screening history (C recommendation). JAMA Report Video
May 18, 2021 · Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force | Cancer Screening, Prevention, Control | JAMA | JAMA Network. Abstract. Introduction. Methods. Results. Discussion. Conclusions. Article Information. References. Figure 1. Analytic Framework: Screening for Colorectal Cancer.
May 18, 2021 · The USPSTF has lowered the age to begin colorectal cancer screening from age 50 to age 45, now recommending colorectal cancer screening for average risk individuals ages 45 to age 75 to reduce their risk of dying from this disease.
May 19, 2021 · May 19, 2021. Updated USPSTF Colorectal Cancer Screening Guidelines Will Help Save Lives. Share Recommend Bookmark. CT Colonography Named Recommended Screening Exam for Full USPSTF Screening Population. Judy Yee, MD, FACR, Chair of the. ACR Colon Cancer Committee.
May 1, 2021 · Screening for Colorectal Cancer: An Evidence Update for the U.S. Preventive Services Task Force. Evidence Synthesis, No. 202. Investigators: Jennifer S. Lin, MD, MCR, Leslie A. Perdue, MPH, Nora B. Henrikson, PhD, MPH, Sarah I. Bean, MPH, and Paula R. Blasi, MPH. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May.
"Screening is recommended for all individuals from age 50 to age 75 (an “A” recommendation); it is recommended that the decision to screen individuals aged 76 to 85 years be individualized based on screening history and overall health status (a “C” recommendation).
